Matthias Fischer is the founder and Managing Director of Canymed, a subsidiary of Grunhorn, Germany's largest cannabis supply chain. He shares insights into how Grunhorn is building its seed-to-sale operation and supporting medical research through its robust data collection. We talk about the industry's bottlenecks and what needs to be done for the cannabis industry to flourish in Europe.
https://www.gruenhorn.de
https://www.canymed.com
Contact: Maja Hoock: m.hoock@gruenhorn.de